ARCHIVES

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Arnold Brown Will Be Appointed NCI Director; Rauscher, Staff “Couldn’t Be More Pleased”

October 22, 1976

Kirsten Goldberg Leaves The Cancer Letter For ASCO

January 7, 2011

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999